The combined treatment with L-arginine and methylprednisolone improves graft morphology and mucosal barrier function

Transplant Proc. 2002 May;34(3):996-8. doi: 10.1016/s0041-1345(02)02760-4.

Authors

H B Warnecke¹, A Schirmeier, A K Nüssler, K P Platz, B Stange, N C Nüssler, C Radke, P Neuhaus, A R Mueller

Affiliation

¹ Department of Surgery, Humboldt University of Berlin, Berlin, Germany.

PMID: 12034278
DOI: 10.1016/s0041-1345(02)02760-4

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Animals
Arginine / pharmacology*
Graft Survival / drug effects
Graft Survival / physiology*
Intestinal Mucosa / drug effects
Intestinal Mucosa / physiology*
Intestinal Mucosa / transplantation
Intestine, Small / drug effects
Intestine, Small / physiology
Intestine, Small / transplantation*
Methylprednisolone / pharmacology*
Molsidomine / pharmacology
Rats
Rats, Inbred Lew
Reperfusion Injury / prevention & control*
Transplantation, Isogeneic / pathology
Transplantation, Isogeneic / physiology*
Vasodilator Agents / pharmacology

Substances

Vasodilator Agents
Arginine
Molsidomine
Methylprednisolone